SESN Shares Outstanding History



Below is a table of the SESN shares outstanding history going back to 2/6/2014:

Date SESN Shares Outstanding
2/6/201414.69M
3/21/201416.24M
5/12/201416.26M
8/8/201416.27M
11/6/201416.29M
3/1/201518.11M
4/17/201519.37M
7/31/201519.38M
10/31/201519.59M
3/15/201619.68M
4/30/201619.88M
7/31/201620.06M
10/31/201624.24M
3/23/201724.70M
4/30/201724.70M
8/11/201724.70M
11/15/201731.83M
3/30/201843.11M
5/10/201848.39M
8/10/201877.01M
11/7/201877.46M
2/27/201977.46M
5/8/201977.46M
8/6/2019101.27M
9/9/201913.63M
11/7/2019104.68M
2/29/2020109.99M
5/4/2020110.42M
8/3/2020117.17M
11/2/2020129.34M
3/8/2021167.58M
5/3/2021173.29M
8/2/2021196.00M
11/1/2021199.46M
2/21/2022199.46M
5/2/2022199.46M
8/1/2022199.46M
10/31/2022202.76M
2/21/2023203.49M

Also see: SESN Market Cap History
SESN YTD Return
SESN Historical Shares Outstanding:
+33.71% CAGR
SESN Historical Shares Outstanding: +33.71% CAGR

Mouse over chart for data details
2/6/2014 ...2/21/2023
Sesen Bio is a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer. Co.'s main product candidate Vicinium (VB4-845), is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive carcinoma in situ of the bladder in patients previously treated with adequate or less than adequate bacillus Calmette-Guerin. Co.'s lead systemically-administered product candidate, VB6-845d, is being developed as a treatment for multiple types of EpCAM-positive solid tumors. We show 39 historical shares outstanding datapoints in our coverage of SESN's shares outstanding history.

Understanding the changing numbers of SESN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SESN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SESN by allowing them to research SESN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree SESN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sesen Bio (SESN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

SGEN Shares Outstanding History
SGFY Shares Outstanding History
SGHT Shares Outstanding History
SGMO Shares Outstanding History
SGMT Shares Outstanding History
SGRY Shares Outstanding History
SGTX Shares Outstanding History
SGYP Shares Outstanding History
SHC Shares Outstanding History
SHOT Shares Outstanding History
More Healthcare companies »

 

SESN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.